Financhill
Buy
61

TCMD Quote, Financials, Valuation and Earnings

Last price:
$17.02
Seasonality move :
8.2%
Day range:
$16.82 - $17.65
52-week range:
$11.12 - $21.10
Dividend yield:
0%
P/E ratio:
26.15x
P/S ratio:
1.43x
P/B ratio:
1.96x
Volume:
359.3K
Avg. volume:
356.4K
1-year change:
23.91%
Market cap:
$408M
Revenue:
$274.4M
EPS (TTM):
$0.65
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $189.5M $187.1M $208.1M $246.8M $274.4M
Revenue Growth (YoY) 31.82% -1.25% 11.18% 18.61% 11.2%
 
Cost of Revenues $55.3M $54.3M $59.8M $70.8M $79.3M
Gross Profit $134.2M $132.8M $148.2M $176M $195.1M
Gross Profit Margin 70.84% 70.97% 71.24% 71.31% 71.11%
 
R&D Expenses $5.2M $5.3M $5.7M $7.1M $7.8M
Selling, General & Admin $118.4M $131M $143.6M $167.2M $169.2M
Other Inc / (Exp) $631K $1.4M -$531K -$2.7M -$2.3M
Operating Expenses $123.7M $136.4M $150M $188.7M $177.1M
Operating Income $10.5M -$3.6M -$1.8M -$12.8M $18M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $11.1M -$2.3M -$2.3M -$15.5M $15.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $158K -$1.6M $9.5M $2.4M -$12.7M
Net Income to Company $11M -$620K -$11.8M -$17.9M $28.5M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $11M -$620K -$11.8M -$17.9M $28.5M
 
Basic EPS (Cont. Ops) $0.58 -$0.03 -$0.60 -$0.89 $1.24
Diluted EPS (Cont. Ops) $0.56 -$0.03 -$0.60 -$0.89 $1.23
Weighted Average Basic Share $18.9M $19.3M $19.7M $20.1M $22.9M
Weighted Average Diluted Share $19.6M $19.3M $19.7M $20.1M $23.2M
 
EBITDA $14M -$834K $1.9M $1.7M $24.5M
EBIT $10.5M -$3.6M -$1.8M -$12.8M $18M
 
Revenue (Reported) $189.5M $187.1M $208.1M $246.8M $274.4M
Operating Income (Reported) $10.5M -$3.6M -$1.8M -$12.8M $18M
Operating Income (Adjusted) $10.5M -$3.6M -$1.8M -$12.8M $18M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $49.1M $52.5M $65.3M $69.6M $73.1M
Revenue Growth (YoY) -1.05% 6.94% 24.32% 6.63% 5.04%
 
Cost of Revenues $14.1M $15.5M $18.5M $20.2M $18.3M
Gross Profit $35M $37M $46.8M $49.4M $54.8M
Gross Profit Margin 71.24% 70.42% 71.7% 70.93% 74.96%
 
R&D Expenses $1.1M $1.4M $1.6M $2M $2.4M
Selling, General & Admin $32M $36.7M $42.8M $42.5M $45M
Other Inc / (Exp) -$121K -$120K -$736K $2.7M $452K
Operating Expenses $33.2M $38.3M $48.4M $44.4M $48M
Operating Income $1.8M -$1.4M -$1.6M $4.9M $6.8M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $1.7M -$1.5M -$2.4M $7.6M $7.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$751K $1.9M -$77K -$14.7M $2.1M
Net Income to Company $2.4M -$3.4M -$2.3M $22.3M $5.2M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $2.4M -$3.4M -$2.3M $22.3M $5.2M
 
Basic EPS (Cont. Ops) $0.12 -$0.17 -$0.11 $0.95 $0.21
Diluted EPS (Cont. Ops) $0.12 -$0.17 -$0.11 $0.94 $0.21
Weighted Average Basic Share $19.4M $19.8M $20.1M $23.5M $24M
Weighted Average Diluted Share $19.7M $19.8M $20.1M $23.8M $24.3M
 
EBITDA $2.4M -$504K $2.4M $6.6M $8.5M
EBIT $1.8M -$1.4M -$1.6M $4.9M $6.8M
 
Revenue (Reported) $49.1M $52.5M $65.3M $69.6M $73.1M
Operating Income (Reported) $1.8M -$1.4M -$1.6M $4.9M $6.8M
Operating Income (Adjusted) $1.8M -$1.4M -$1.6M $4.9M $6.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $185M $205.6M $234.6M $270.7M $285.1M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $52.9M $60.3M $65.9M $79.4M $76.7M
Gross Profit $132.1M $145.3M $168.7M $191.2M $208.3M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $5.1M $5.3M $6.7M $8.2M $8.6M
Selling, General & Admin $131.3M $138.2M $165.5M $167.9M $175.7M
Other Inc / (Exp) $314K $1M -$2.1M -$112K $239K
Operating Expenses $136.6M $143.8M $185.5M $180.2M $186.3M
Operating Income -$4.6M $1.5M -$16.8M $11M $22M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$4.2M $2.5M -$19M $10.9M $22.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $4.2M -$5.3M $11M -$14M $6.8M
Net Income to Company -$8.5M $7.8M -$30M $24.9M $15.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$8.5M $7.8M -$30M $24.9M $15.4M
 
Basic EPS (Cont. Ops) -$0.45 $0.40 -$1.50 $1.09 $0.65
Diluted EPS (Cont. Ops) -$0.45 $0.39 -$1.50 $1.08 $0.65
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$1.7M $4.3M -$2.5M $17.6M $28.7M
EBIT -$4.6M $1.5M -$16.8M $11M $22M
 
Revenue (Reported) $185M $205.6M $234.6M $270.7M $285.1M
Operating Income (Reported) -$4.6M $1.5M -$16.8M $11M $22M
Operating Income (Adjusted) -$4.6M $1.5M -$16.8M $11M $22M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $127.9M $146.3M $172.9M $196.8M $207.4M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $36.9M $42.9M $49M $57.6M $55.1M
Gross Profit $91M $103.4M $123.9M $139.1M $152.3M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $3.9M $3.9M $5M $6M $6.8M
Selling, General & Admin $97.6M $104.8M $126.7M $127.4M $134M
Other Inc / (Exp) $181K -$154K -$1.8M $838K $832K
Operating Expenses $101.6M $108.9M $144.5M $136M $142.7M
Operating Income -$10.6M -$5.5M -$20.6M $3.2M $9.7M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$10.4M -$5.7M -$22.4M $4M $10.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $2.3M -$1.4M $114K -$16.3M $3.3M
Net Income to Company -$12.7M -$4.3M -$22.5M $20.3M $7.2M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$12.7M -$4.3M -$22.5M $20.3M $7.2M
 
Basic EPS (Cont. Ops) -$0.67 -$0.22 -$1.12 $0.86 $0.30
Diluted EPS (Cont. Ops) -$0.67 -$0.22 -$1.12 $0.85 $0.30
Weighted Average Basic Share $57.9M $59M $60.1M $68.1M $71.5M
Weighted Average Diluted Share $58.3M $59.4M $60.1M $68.5M $72M
 
EBITDA -$8.5M -$3.4M -$7.8M $8.1M $14.7M
EBIT -$10.6M -$5.5M -$20.6M $3.2M $9.7M
 
Revenue (Reported) $127.9M $146.3M $172.9M $196.8M $207.4M
Operating Income (Reported) -$10.6M -$5.5M -$20.6M $3.2M $9.7M
Operating Income (Adjusted) -$10.6M -$5.5M -$20.6M $3.2M $9.7M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $22.8M $47.9M $28.2M $21.9M $61M
Short Term Investments $30.6M $10.7M $12.5M $16.1M $14.2M
Accounts Receivable, Net $33.4M $43.8M $49.5M $54.8M $43.2M
Inventory $19.1M $18.6M $19.2M $23.1M $22.5M
Prepaid Expenses -- -- -- -- --
Other Current Assets $2.5M $2.6M $4.1M $3.8M $4.4M
Total Current Assets $108.3M $123.6M $113.5M $119.8M $145.3M
 
Property Plant And Equipment $23.3M $27.1M $30.7M $27.4M $25.3M
Long-Term Investments -- -- -- -- --
Goodwill -- -- $31.1M $31.1M $31.1M
Other Intangibles $5.3M $1.7M $54.1M $50.4M $46.7M
Other Long-Term Assets $1.7M $2.1M $2M $3.3M $2.7M
Total Assets $151.8M $174.1M $244.3M $255M $281.4M
 
Accounts Payable $3.8M $4.2M $5M $10M $6.7M
Accrued Expenses $13.2M $14.2M $17.3M $26.2M $22.5M
Current Portion Of Long-Term Debt -- -- $3M $3M $3M
Current Portion Of Capital Lease Obligations $1.5M $2M $2.5M $2.5M $2.8M
Other Current Liabilities $903K $1.8M $6.6M $20.2M $4.5M
Total Current Liabilities $21.4M $26.7M $34.5M $64.3M $41.1M
 
Long-Term Debt -- -- $51.8M $45.9M $26.2M
Capital Leases -- -- -- -- --
Total Liabilities $39.2M $49.3M $116M $133.6M $87.8M
 
Common Stock $19K $19K $20K $20K $24K
Other Common Equity Adj $26K -- -- -- --
Common Equity $112.6M $124.8M $128.2M $121.4M $193.6M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $112.6M $124.8M $128.2M $121.4M $193.6M
 
Total Liabilities and Equity $151.8M $174.1M $244.3M $255M $281.4M
Cash and Short Terms $53.4M $58.6M $40.7M $38.1M $75.2M
Total Debt -- -- $54.8M $48.9M $29.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $42.2M $22.4M $23.4M $66M $82.1M
Short Term Investments $9.5M $12.4M $15.1M $13.6M $14M
Accounts Receivable, Net $36M $44.3M $51.8M $43.9M $40M
Inventory $22.4M $23.8M $23M $23.5M $21.2M
Prepaid Expenses -- -- -- -- --
Other Current Assets $4M $3.7M $3.5M $4.7M $5.1M
Total Current Assets $114.1M $106.6M $116.8M $151.7M $162.4M
 
Property Plant And Equipment $27.9M $30.4M $28.7M $24.8M $23.4M
Long-Term Investments -- -- -- -- --
Goodwill -- $31.1M $31.1M $31.1M $31.1M
Other Intangibles $1.7M $55M $51.3M $47.6M $43.7M
Other Long-Term Assets $2M $2.1M $3M $2.8M $3.8M
Total Assets $157.8M $249.4M $248.5M $293.3M $287.7M
 
Accounts Payable $5.1M $6.2M $11.2M $6.4M $7.3M
Accrued Expenses $12.8M $13.8M $18.7M $20M $20M
Current Portion Of Long-Term Debt -- -- $3M $3M $3M
Current Portion Of Capital Lease Obligations $2M $2.4M $2.5M $2.6M $2.9M
Other Current Liabilities $2.7M $3.7M $18.5M $11.5M $3.2M
Total Current Liabilities $25.6M $31.3M $55.7M $45.6M $37.2M
 
Long-Term Debt -- $52.5M $46.6M $43.6M $24M
Capital Leases -- -- -- -- --
Total Liabilities $48.6M $117.3M $134.1M $110.5M $79.8M
 
Common Stock $19K $20K $20K $23K $24K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $109.1M $132.1M $114.4M $182.8M $207.9M
 
Total Liabilities and Equity $157.8M $249.4M $248.5M $293.3M $287.7M
Cash and Short Terms $51.7M $34.8M $38.5M $79.6M $96.1M
Total Debt -- $54.7M $49.6M $46.5M $26.9M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $11M -$620K -$11.8M -$17.9M $28.5M
Depreciation & Amoritzation $3.5M $2.8M $3.7M $6.3M $6.5M
Stock-Based Compensation $9.8M $10.7M $10.2M $9.6M $7.5M
Change in Accounts Receivable -$11.4M -$15.7M -$9M -$15.6M $23.8M
Change in Inventories -$7.9M $318K $972K -$3.9M $597K
Cash From Operations $2.5M $2.8M $2.6M $5.2M $35.9M
 
Capital Expenditures $6M $2.3M $2.4M $1.9M $2.5M
Cash Acquisitions -- -- -$79.8M -- --
Cash From Investing -$2.3M $20.2M -$82.2M -$1.9M -$2.5M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- $55M -- $8.3M
Long-Term Debt Repaid -- -- -- -$6M -$28M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$3.4M -$1.9M -$1.4M -$5M -$10.7M
Cash From Financing $2.5M $2.1M $59.9M -$9.6M $5.7M
 
Beginning Cash (CF) $20.1M $22.8M $47.9M $28.2M $21.9M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $2.7M $25.1M -$19.6M -$6.3M $39.1M
Ending Cash (CF) $22.8M $47.9M $28.2M $21.9M $61M
 
Levered Free Cash Flow -$3.5M $503K $276K $3.3M $33.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $2.4M -$3.4M -$2.3M $22.3M $5.2M
Depreciation & Amoritzation $652K $863K $1.7M $1.6M $1.7M
Stock-Based Compensation $3.2M $2.6M $2.6M $1.8M $2.1M
Change in Accounts Receivable -$6.7M -$2.2M -$5M $3.5M $2.8M
Change in Inventories $2.4M -$1.1M -$3.1M -$3.2M -$2.3M
Cash From Operations $5.7M -$1.1M $2.3M $4.1M $10.3M
 
Capital Expenditures $1M $665K $1.4M $399K $978K
Cash Acquisitions -- -$79.8M -- -- --
Cash From Investing $5M -$80.5M -$1.4M -$399K -$978K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $55M -- $8.3M --
Long-Term Debt Repaid -- -- -$750K -$9M -$750K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$39K -$253K -- -$125K --
Cash From Financing $175K $54.9M -$750K -$873K -$750K
 
Beginning Cash (CF) $31.3M $49M $23.4M $63.2M $73.6M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $10.9M -$26.6M $76K $2.8M $8.5M
Ending Cash (CF) $42.2M $22.4M $23.4M $66M $82.1M
 
Levered Free Cash Flow $4.7M -$1.7M $826K $3.7M $9.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$8.5M $7.8M -$30M $24.9M $15.4M
Depreciation & Amoritzation $2.8M $2.8M $6.2M $6.5M $6.7M
Stock-Based Compensation $10.7M $10.1M $10.2M $7.5M $7.9M
Change in Accounts Receivable -$12.4M -$13.5M -$12.8M $11M $14.9M
Change in Inventories -$5.7M $215K $810K -$478K $2.3M
Cash From Operations -$2.2M $2.1M $7M $21.4M $42.7M
 
Capital Expenditures $3.3M $1.9M $2.8M $1.6M $3M
Cash Acquisitions -- -$79.8M -- -- --
Cash From Investing $21.6M -$81.7M -$2.8M -$1.6M -$2.9M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -$5.3M -$11.3M -$19.8M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$1.9M -$1.6M -$32K -- --
Cash From Financing $2.9M $59.9M -$3.1M $22.9M -$23.6M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $22.4M -$19.8M $1M $42.6M $16.1M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$5.5M $151K $4.2M $19.7M $39.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$12.7M -$4.3M -$22.5M $20.3M $7.2M
Depreciation & Amoritzation $2.1M $2.2M $4.7M $4.9M $5.1M
Stock-Based Compensation $8.3M $7.7M $7.7M $5.6M $6M
Change in Accounts Receivable -$5.5M -$3.4M -$7.2M $19.4M $10.5M
Change in Inventories -$3.5M -$3.6M -$3.8M -$374K $1.4M
Cash From Operations -$2.2M -$3M $1.4M $17.5M $24.3M
 
Capital Expenditures $1.8M $1.4M $1.8M $1.5M $2M
Cash Acquisitions -- -$79.8M -- -- --
Cash From Investing $20.7M -$81.2M -$1.8M -$1.5M -$2M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $55M -- $8.3M --
Long-Term Debt Repaid -- -- -$5.3M -$10.5M -$2.3M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$1.6M -$1.4M -$39K -$5.1M --
Cash From Financing $995K $58.8M -$4.3M $28.1M -$1.2M
 
Beginning Cash (CF) $86.4M $143.8M $72.7M $140.2M $195.4M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $19.4M -$25.5M -$4.8M $44.1M $21.1M
Ending Cash (CF) $105.8M $118.3M $67.9M $184.3M $216.5M
 
Levered Free Cash Flow -$4M -$4.4M -$490K $16M $22.3M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock